Skip to content
← Back to this collection

PUBLICATIONS · 33844595

Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Aug 1
First author
Alva AS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Aug 1;39(22):2426-2429. doi: 10.1200/JCO.21.00552.
    note
    Source null
    related pmid
    33979191
    relationship
    Comment in

Authors and identifiers

  1. name
    Alva AS
    type
    Author
  2. name
    Mangat PK
    type
    Author
  3. name
    Garrett-Mayer E
    type
    Author
  4. name
    Halabi S
    type
    Author
  5. name
    Hansra D
    type
    Author
  6. name
    Calfa CJ
    type
    Author
  7. name
    Khalil MF
    type
    Author
  8. name
    Ahn ER
    type
    Author
  9. name
    Cannon TL
    type
    Author
  10. name
    Crilley P
    type
    Author
  11. name
    Fisher JG
    type
    Author
  12. name
    Haslem DS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Alva AS
    type
    Author
  2. name
    Mangat PK
    type
    Author
  3. name
    Garrett-Mayer E
    type
    Author
  4. name
    Halabi S
    type
    Author
  5. name
    Hansra D
    type
    Author
  6. name
    Calfa CJ
    type
    Author
  7. name
    Khalil MF
    type
    Author
  8. name
    Ahn ER
    type
    Author
  9. name
    Cannon TL
    type
    Author
  10. name
    Crilley P
    type
    Author
  11. name
    Fisher JG
    type
    Author
  12. name
    Haslem DS
    type
    Author
bibliography ids
  1. nci-bib-51731cc5e123c7d21e548e40
book metadata
content sha256
b8b658ee64d871118de13ba899480ff2995acd208323a60d7c016c1e6619fc5f
document type
citation
dois
  1. 10.1200/JCO.20.02923
electronic publication date
display
2021 Apr 12
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:33844595
immutable id
pubmed:33844595@b8b658ee64d871118de13ba899480ff2995acd208323a60d7c016c1e6619fc5f
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
22
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2443-2451
volume
39
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Aug 1;39(22):2426-2429. doi: 10.1200/JCO.21.00552.
    note
    Source null
    related pmid
    33979191
    relationship
    Comment in
outcomes validated
false
pmid
33844595
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
0e1afe57f075fc3a537b43258c8745d51cefc254ba552d7591a8d31d00829454
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Aug 1
precision
day
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33844595/
title
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Preserved source evidence · Not medical advice